我们研究了使用血管紧张素受体阻断剂（ARB）进行治疗是否能延缓或预防尿白蛋白正常的2型糖尿病患者出现微量蛋白尿。

We investigated whether treatment with an angiotensin-receptor blocker (ARB) would delay or prevent the occurrence of microalbuminuria in patients with type 2 diabetes and normoalbuminuria.

youdao

目前，我认为血管紧张素受体阻断剂是耐受更好的肾素-血管紧张素系统阻滞剂，因此我会在联合策略中包括这种药物。

I think at the moment, the angiotensin receptor blockers are the better tolerated blockers of the renin-angiotensin system, so I would include those in a combination.

youdao